MARKET

EOLS

EOLS

EVOLUS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.095
-0.105
-3.29%
Opening 09:53 07/13 EDT
OPEN
3.170
PREV CLOSE
3.200
HIGH
3.230
LOW
3.060
VOLUME
123.92K
TURNOVER
--
52 WEEK HIGH
20.27
52 WEEK LOW
3.000
MARKET CAP
104.38M
P/E (TTM)
-0.9075
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average EOLS stock price target is 13.00 with a high estimate of 35.00 and a low estimate of 3.000.

EPS

EOLS News

More
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD)
Benzinga · 3d ago
Lost Money in Evolus, Inc.?
Business Wire · 4d ago
Hedge Funds Are Selling Evolus, Inc. (EOLS)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds
Insider Monkey · 4d ago
65 Biggest Movers From Yesterday
Gainers MOGU Inc. (NASDAQ: MOGU) shares climbed 104.8% to close at $5.92 on Tuesday.
Benzinga · 5d ago
Mid-Afternoon Market Update: Dow Drops Over 200 Points; Evolus Shares Plunge
Toward the end of trading Tuesday, the Dow traded down 0.82% to 26070.67 while the NASDAQ fell 0.11% to 10422.11. The S&P also fell, dropping 0.42% to 3,166.23.
Benzinga · 5d ago
NVAX, MFGP, RUN and TOPS among midday movers
Seeking Alpha - Article · 5d ago
51 Stocks Moving In Tuesday's Mid-Day Session
Gainers
Benzinga · 5d ago
Mid-Day Market Update: Remark Holdings Falls After Q1 Results; Corvus Pharmaceuticals Shares Jump
Midway through trading Tuesday, the Dow traded down 0.51% to 26153.90 while the NASDAQ rose 0.80% to 10,517.24. The S&P also rose, gaining 0.11% to 3,183.22.
Benzinga · 5d ago

Industry

Biotechnology & Medical Research
+1.14%
Pharmaceuticals & Medical Research
+1.01%

Hot Stocks

Symbol
Price
%Change

About EOLS

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.
More

Webull offers kinds of Evolus Inc stock information, including NASDAQ:EOLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EOLS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EOLS stock methods without spending real money on the virtual paper trading platform.